SynthesisClinical drug investigation2017

Adverse Events and Efficacy of Cixutumumab in Phase II Clinical Trials: A systematic Review and Meta-Analysis.

Hongxin Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.